ZA711242B - Use of lysolecithins as immunological adjuvants - Google Patents

Use of lysolecithins as immunological adjuvants

Info

Publication number
ZA711242B
ZA711242B ZA711242A ZA711242A ZA711242B ZA 711242 B ZA711242 B ZA 711242B ZA 711242 A ZA711242 A ZA 711242A ZA 711242 A ZA711242 A ZA 711242A ZA 711242 B ZA711242 B ZA 711242B
Authority
ZA
South Africa
Prior art keywords
lysolecithins
immunological adjuvants
immunological
adjuvants
Prior art date
Application number
ZA711242A
Other languages
English (en)
Inventor
P Munder
H Fischer
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of ZA711242B publication Critical patent/ZA711242B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
ZA711242A 1970-02-27 1971-02-26 Use of lysolecithins as immunological adjuvants ZA711242B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2009343A DE2009343C3 (de) 1970-02-27 1970-02-27 Verwendung von Lysolecithinen als immunologische Adjuvantien

Publications (1)

Publication Number Publication Date
ZA711242B true ZA711242B (en) 1971-12-29

Family

ID=5763599

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA711242A ZA711242B (en) 1970-02-27 1971-02-26 Use of lysolecithins as immunological adjuvants

Country Status (7)

Country Link
US (1) US3752886A (xx)
BE (1) BE763580A (xx)
DE (1) DE2009343C3 (xx)
FR (1) FR2081547B1 (xx)
GB (1) GB1334138A (xx)
NL (1) NL7102368A (xx)
ZA (1) ZA711242B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
DE2619686C2 (de) * 1976-05-04 1986-08-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verwendung eines Lysolecithins zur Tumorbehandlung
GB2046092B (en) * 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
US4439199A (en) * 1980-02-19 1984-03-27 Alza Corporation Method for administering immunopotentiator
US4455142A (en) * 1980-07-07 1984-06-19 Alza Corporation Method of coadministering an antigen and an immunopotentiator
US4484923A (en) * 1982-03-25 1984-11-27 Alza Corporation Method for administering immunopotentiator
US4666893A (en) * 1983-02-15 1987-05-19 St. Thomas Institute Methods of inducing resistance to bacterial and viral infections
JPS6045518A (ja) * 1983-08-22 1985-03-12 Takeda Chem Ind Ltd 抗シヨツク剤
US4923854A (en) * 1986-01-22 1990-05-08 The Liposome Company, Inc. Solubilization of hydrophobic materials using lysophospholipid
US5084269A (en) * 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
DE3918082A1 (de) * 1989-06-02 1991-01-24 Max Planck Gesellschaft Mittel gegen autoimmunerkrankungen
IE912535A1 (en) * 1990-07-27 1992-01-29 Res Dev Foundation Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens
CA2092731A1 (en) * 1993-03-26 1994-09-27 Yaping Shen Mirror amide cord factors and mirror thioesther cord factors for diagnosis of tuberculosis
PT785773E (pt) * 1994-10-14 2001-05-31 Liposome Co Inc Lipossomas de eteres lipidicos e sua utilizacao terapeutica
US5942246A (en) * 1996-02-16 1999-08-24 The Liposome Company, Inc. Etherlipid containing multiple lipid liposomes
US6667053B1 (en) 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US6007839A (en) * 1996-02-16 1999-12-28 The Liposome Company, Inc. Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes
USRE39042E1 (en) * 1996-02-16 2006-03-28 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US5965159A (en) 1996-02-16 1999-10-12 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US5932242A (en) * 1996-10-15 1999-08-03 The Liposome Company, Inc. Ether lipid-containing pharmaceutical compositions and therapeutic uses thereof

Also Published As

Publication number Publication date
NL7102368A (xx) 1971-08-31
DE2009343C3 (de) 1980-10-23
BE763580A (fr) 1971-08-26
FR2081547A1 (xx) 1971-12-03
GB1334138A (en) 1973-10-17
DE2009343A1 (de) 1971-09-02
FR2081547B1 (xx) 1974-03-22
US3752886A (en) 1973-08-14
DE2009343B2 (de) 1980-02-28

Similar Documents

Publication Publication Date Title
ZA711242B (en) Use of lysolecithins as immunological adjuvants
ZA713034B (en) The preparation of fish
CA942308A (en) Preparation of 2-trifluoromethylquinoxaline-di-n-oxides
CA989418A (en) Preparation of phenylaminoethanols
ZA715544B (en) Vaccine preparation
ZA713521B (en) Preparation of mercaptoethanol
IL35887A (en) The preparation of isoxazolylethyl substituted tetrahydropyranols
IL36828A0 (en) Preparation of alkylene-dioxyheptanones
CA920608A (en) Preparation of dihydroterephthalates
ZA71546B (en) Use of trichloroimidazole as herbicide
IL41199A0 (en) The use of certain imidazothiazoles as vaccine adjuvants
JPS5445395A (en) Preparation of halohydrine
CA933946A (en) Preparation of 4-mercaptophenols
IL37101A (en) The preparation of alkyl 2-benzimidazole-carbamates
IL38078A0 (en) The preparation of substituted dithiobiurets
IL37994A0 (en) Preparation of 1-alkyl-2-aminomethylpyrrolidines
PH9845A (en) Preparation of 2-benzoylalkylbenzomorphan
AU459209B2 (en) Immunological adjuvants
CA873873A (en) Preparation of adamantane-d16
CA926400A (en) Preparation of 4-aminophenols
CA842810A (en) Preparation of 2-thioamidobenzomorphans
CA845734A (en) Preparation of chlorothiophenols
CA851177A (en) Preparation of steroidal-3-enamines
CA857394A (en) Preparation of alpha-triorganosiloxy-omega-hydroxy-diorganopolysiloxanes
CA859723A (en) Preparation of gonatrienols